Huy Ong B Pharm, PhD, Emeritus Professor of Faculty of Pharmacy Université de Montréal, was honored by the 2018 Association of the Faculties of Pharmacy of Canada with the Pfizer Research Career Award for his pioneering endocrine research aimed at developing therapeutics for cardiovascular diseases. In the 1990s, his groundbreaking endocrine research led to the discovery of an aldosterone secretion inhibitory factor in the adrenal medulla, later identified as the elongated form of the brain natriuretic peptide BNP (Endo, Mol. Endo., 1989). Since 2000, his translational research focused on therapies for chronic inflammatory diseases such as atherosclerosis and age-related macular degeneration, resulting in the identification of growth hormone-releasing peptides as modulating ligands for the scavenger receptor CD36 (Circ. Res., 1999; 2002) This work contributed to the development of therapeutic prototypes as negative modulators of atherosclerosis and hypercholesterolemia. A member of the Endocrine Society, he has published over 230 peer-reviewed articles, five international patents and four book chapters. He has supervised 40 graduate students and postdoctoral fellows.